National Yang Ming Chiao Tung University

Yun-Ti Chen

Jinn-Moon Yang

Ming-Lung Yu

Shey-Cherng Tzou

Hsiao-Chen Huang

Nung-Yu Hsu

Po-Shiuan Hsieh

Nikhil Pathak

Jung-Yu Lee

Yu-Hsiu Chang

Chih-Heng Huang

Yen-Chao Hsu

Disclosed herein is a method for alleviating a chronic liver disease, comprising administrating to a subject in need thereof a pharmaceutical composition containing rosoxacin.

Method for alleviating chronic liver disease using Rosoxacin

Disclosed herein is a method against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The method includes administering to a subject in need thereof a first active ingredient selected from the group consisting of methotrexate (MIX) and a pharmaceutically acceptable salt thereof, and a second active ingredient selected from the group consisting of remdesivir and a pharmaceutically acceptable salt thereof. A molar ratio of the first active ingredient to the second active ingredient ranges from 1:13 to 1:25.

Method against severe acute respiratory syndrome coronavirus 2 infection

Growing community of inventors

Tainan, Taiwan

Yun-Ti Chen